News
NWBO
0.192
-3.08%
-0.006
Weekly Report: what happened at NWBO last week (0601-0605)?
Weekly Report · 1d ago
Weekly Report: what happened at NWBO last week (0525-0529)?
Weekly Report · 06/01 09:45
First Berlin reiterates Buy on Northwest Biotherapeutics, keeps USD 1 price target
PUBT · 05/28 11:43
Weekly Report: what happened at NWBO last week (0518-0522)?
Weekly Report · 05/25 09:47
Weekly Report: what happened at NWBO last week (0511-0515)?
Weekly Report · 05/18 09:46
Northwest Bio narrows Q1 net loss to $3.1 million
PUBT · 05/15 20:42
Weekly Report: what happened at NWBO last week (0504-0508)?
Weekly Report · 05/11 09:44
Weekly Report: what happened at NWBO last week (0427-0501)?
Weekly Report · 05/04 09:44
Northwest Biotherapeutics names Annalisa Jenkins as strategic advisor
TipRanks · 04/30 17:45
Northwest Bio appoints Annalisa Jenkins as strategic adviser
PUBT · 04/30 16:31
NORTHWEST BIOTHERAPEUTICS APPOINTS DR. ANNALISA JENKINS AS STRATEGIC ADVISER TO ADVANCE DENDRITIC CELL CANCER VACCINE PLATFORM
Reuters · 04/30 16:31
Weekly Report: what happened at NWBO last week (0420-0424)?
Weekly Report · 04/27 09:45
Northwest Biotherapeutics establishes dedicated leukapheresis clinic
TipRanks · 04/21 14:53
Northwest Bio establishes dedicated leukapheresis clinic at London Welbeck Hospital
PUBT · 04/21 13:30
NORTHWEST BIOTHERAPEUTICS ANNOUNCES ESTABLISHMENT OF THE COMPANY'S OWN DEDICATED LEUKAPHERESIS CLINIC
Reuters · 04/21 13:30
Weekly Report: what happened at NWBO last week (0413-0417)?
Weekly Report · 04/20 09:43
Weekly Report: what happened at NWBO last week (0406-0410)?
Weekly Report · 04/13 09:45
Northwest Biotherapeutics Completes Advent BioServices Acquisition Deal
TipRanks · 04/07 16:57
Northwest Bio completes acquisition of UK CDMO Advent BioServices for $1.9 million
Reuters · 04/07 16:31
Weekly Report: what happened at NWBO last week (0330-0403)?
Weekly Report · 04/06 09:45
More
Webull provides a variety of real-time NWBO stock news. You can receive the latest news about Northwest Bio through multiple platforms. This information may help you make smarter investment decisions.
About NWBO
Northwest Biotherapeutics, Inc. is a biotechnology company. The Company is focused on developing personalized immune therapies for cancer. It has developed a platform technology, DCVax, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. The Company's product line includes DCVax-L and DCVax-Direct. DCVax-L is designed to treat solid tumor cancers in which the tumors can be surgically removed. It has completed a 331-patient international Phase III trial of DCVax-L for Glioblastoma multiforme brain cancer (GBM). DCVax-Direct is designed to treat inoperable solid tumors. A 40-patient Phase I trial has been completed and includes treatment of a diverse range of more than a dozen types of cancers. Its subsidiaries include Flaskworks LLC, NW Bio GmbH, Northwest Biotherapeutics Capital Limited, Northwest Biotherapeutics B.V., Advent BioServices Ltd., and others.